companies / ambros-bio
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 125,000,000125.0M | ○ |
|---|---|---|
| founded | 2022 | |
| hq | Irvine CA | |
| industry | unknown | |
| stage | series-a |
Targeted-protein-degradation biotech building bifunctional small molecules to drug previously-undruggable proteins. Sells to pharma partners and patient populations with currently inaccessible oncology and immunology targets. Focused on novel ligase recruiters that expand the chemical space of protein degraders beyond the standard CRBN and VHL toolkits.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-12-01 | series-a | 125,000,000125.0M | null | ○ |
| fact | status | src |
|---|---|---|
| Series A, $125.0M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-18github_org: ambros → unknown, null | github_org | ambros → unknown | null |
Records begin 2026-09-24. all_changes